Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial. (Q36428213)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial. |
scientific article |
Statements
Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial (English)
Christopher Koh
Xiongce Zhao
Susan L Uprichard
Vanessa Haynes-Williams
Mark A Winters
Gitanjali Subramanya
Stewart L Cooper
Peter Pinto
Erin F Wolff
Rachel Bishop
Ma Ai Thanda Han
Scott J Cotler
Onur Keskin
Ramazan Idilman
Cihan Yurdaydin
Jeffrey S Glenn
Theo Heller
16 July 2015